Patients with heart failure eligible to a SGLT2 inhibitor treatment: prevalence, characteristics and costs from a combination of administrative healthcare and primary care databases by Redazione | Dic 14, 2022
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases by Redazione | Dic 14, 2022
